CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 3 filers reported holding CASI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | -100.0% | 264 | -99.8% | 0.00% | – |
| Q4 2021 | $94,000 | +40.3% | 117,917 | +111.1% | 0.00% | – |
| Q3 2021 | $67,000 | -38.5% | 55,858 | -20.4% | 0.00% | – |
| Q2 2021 | $109,000 | -22.7% | 70,169 | +19.4% | 0.00% | – |
| Q1 2021 | $141,000 | +104.3% | 58,764 | +151.5% | 0.00% | – |
| Q4 2020 | $69,000 | +228.6% | 23,368 | +68.1% | 0.00% | – |
| Q3 2020 | $21,000 | -54.3% | 13,902 | -24.8% | 0.00% | – |
| Q2 2020 | $46,000 | +142.1% | 18,490 | +103.7% | 0.00% | – |
| Q1 2020 | $19,000 | -62.7% | 9,075 | -45.2% | 0.00% | – |
| Q4 2019 | $51,000 | -32.9% | 16,565 | -27.2% | 0.00% | – |
| Q3 2019 | $76,000 | +38.2% | 22,752 | +31.7% | 0.00% | – |
| Q2 2019 | $55,000 | +103.7% | 17,272 | +93.0% | 0.00% | – |
| Q1 2019 | $27,000 | -76.9% | 8,949 | -69.1% | 0.00% | – |
| Q4 2018 | $117,000 | +101.7% | 28,954 | +132.9% | 0.00% | – |
| Q3 2018 | $58,000 | -7.9% | 12,433 | +63.8% | 0.00% | – |
| Q2 2018 | $63,000 | +125.0% | 7,589 | +13.4% | 0.00% | – |
| Q1 2018 | $28,000 | +833.3% | 6,695 | +569.5% | 0.00% | – |
| Q4 2017 | $3,000 | +50.0% | 1,000 | -12.6% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 1,144 | -2.3% | 0.00% | – |
| Q2 2017 | $1,000 | -50.0% | 1,171 | +2.4% | 0.00% | – |
| Q1 2017 | $2,000 | +100.0% | 1,144 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -75.0% | 1,144 | -67.9% | 0.00% | – |
| Q3 2016 | $4,000 | +300.0% | 3,562 | +581.1% | 0.00% | – |
| Q2 2016 | $1,000 | – | 523 | +182.7% | 0.00% | – |
| Q1 2016 | $0 | – | 185 | -18.5% | 0.00% | – |
| Q4 2015 | $0 | – | 227 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 227 | -28.4% | 0.00% | – |
| Q2 2015 | $1,000 | – | 317 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | – | 317 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 317 | -10.2% | 0.00% | – |
| Q3 2014 | $1,000 | – | 353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
| Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
| Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
| Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
| Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
| Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
| Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
| FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |